Table 2 Clinical traits at the knee level
N (joints) | KL grade | Knee tender points | Tenderness at the tibial site | Temporal summation | Central sensitization | ||||
|---|---|---|---|---|---|---|---|---|---|
2 | 3 | No | Yes | ||||||
Treatment | CNV | 59 | 13 (22.0%) | 46 (78.0%) | 4.7 (3.5) | 5.0 (4.1) | 1.8 (2.4) | 22 (37.3%) | 37 (62.7%) |
TKR | 39 | 7 (17.9%) | 32 (82.1%) | 5.4 (4.0) | 6.2 (3.5) | 1.9 (2.1) | 14 (37.8%) | 23 (62.2%) | |
Sex | Men | 40 | 6 (15.0%) | 34 (85.0%) | 2.4 (2.7) | 3.8 (3.5) | 1.4 (1.9) | 27 (67.5%) | 13 (32.5%) |
Women | 58 | 14 (24.1%) | 44 (75.9%) | 6.8 (3.3) | 6.7 (3.7) | 2.2 (2.5) | 9 (16.1%) | 47 (83.9%) | |
Age | 60–67 y | 47 | 11 (23.4%) | 36 (76.6%) | 5.8 (3.9) | 5.0 (4.1) | 1.8 (2.3) | 14 (31.1%) | 31 (68.9%) |
68–75 y | 51 | 9 (17.6%) | 42 (82.4%) | 4.3 (3.4) | 5.9 (3.7) | 1.8 (2.2) | 22 (43.1%) | 29 (56.9%) | |
BMI | ≤ 30 kg/m2 | 47 | 11 (23.4%) | 36 (76.6%) | 4.7 (4.0) | 5.0 (3.9) | 1.8 (2.0) | 19 (41.3%) | 27 (58.7%) |
> 30 kg/m2 | 51 | 9 (17.6%) | 42 (82.4%) | 5.3 (3.5) | 5.9 (3.8) | 1.8 (2.5) | 17 (34.0%) | 33 (66.0%) | |